Emanuele Naglieri - Publications

Occult invasive and preneoplastic lesions at risk-reducing salpingo-oophorectomy in BRCA1/2 carriers: A multicenter retrospective cohort study.

Journal: Gynecologic oncology

Published: May 13, 2026

Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study.

Journal: Frontiers in oncology

Published: November 25, 2025

MUC1/CA15-3 identifies a clear cell renal carcinoma characterized by Sunitinib response with a specific metabolic signature.

Journal: Clinical and experimental medicine

Published: October 28, 2025

Histopathology and outcomes of non-metastatic renal cell carcinoma with inferior vena cava tumor thrombus: systematic review and meta-analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 17, 2025

Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study.

Journal: Clinical genitourinary cancer

Published: September 09, 2024

Explainable machine learning for predicting recurrence-free survival in endometrial carcinosarcoma patients.

Journal: Frontiers in artificial intelligence

Published: March 19, 2024

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.

Journal: Cancer immunology, immunotherapy : CII

Published: February 25, 2024

Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.

Journal: Frontiers in immunology

Published: December 24, 2023

Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity.

Journal: Gynecologic oncology

Published: December 15, 2023

Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.

Journal: JAMA network open

Published: November 27, 2023

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.

Journal: Frontiers in oncology

Published: October 23, 2023

An explainable machine learning model to solid adnexal masses diagnosis based on clinical data and qualitative ultrasound indicators.

Journal: Cancer medicine

Published: October 09, 2023